The Biotechnology Innovation Organization (BIO) recently released a report on Bioscience Innovation in the States: Legislation and Job Creation through Public-Private Partnerships. This biennial report provides a good summary of state initiatives serving the industry plus a discussion of new developments and trends by state.
Join BioBuzz and sponsor Immunomic Therapeutics to celebrate the move from allergy to oncology application of their proprietary LAMP-Vax™ technology platform. The celebration will be at Bar Louie in the Rockville Town Center on July 27, 2017 from 5 – 7pm. Only a 5 minute walk from the Rockville Metro, please join us for this exciting event.
The Company:
Noble Life Sciences (Sykesville, MD) is a rapidly growing contract research organization (CRO) that provides preclinical drug, vaccine and medical device development services, from discovery to GLP-compliant studies for regulatory submissions. The company offers in vitro and in vivo services, including cellular and animal disease model development and experimental design, non-GLP and GLP animal efficacy, toxicity, biodistribution and product release studies in both small and large animals. The company also offers custom antibody production services, research animal and tissue products, and vivarium services.
The Position:
The representative will be responsible for selling preclinical services to new accounts in order to achieve sales targets, developing new sales in these accounts by monitoring customer’s existing projects for successful completion to stated goals, and proposing related and new services as they monitor accounts needs for future CRO services.
The representative is expected to use his/her knowledge of the market and external contacts in companies developing drugs, vaccines, and medical devices to increase sales. The representative will implement sales and marketing strategy and tactics to gain new customers and achieve sales and profit goals in designated geographic territory.
Leslie Ford Weber, director of the Johns Hopkins University Montgomery County Campus, has been elected chair-elect of the Montgomery County Chamber of Commerce.
Weber, who is also director of campus, government and community affairs in Montgomery County for the university and Suburban Hospital, previously served the Chamber as vice chair of the legislative affairs committee and will continue in that role as chair-elect. Before that, she was vice chair of the economic development committee.
FULL-TIME POSITION:
Job Summary: BioFactura is seeking highly motivated applicants with an entrepreneurial spirit for an open position in our biosimilar development programs. We are looking for qualified candidates with a masters or doctoral degree in the life sciences with highly relevant skills and bench experience. The selected candidate will participate in the development and validation of various biosimilar product assays. In this position, the candidate will be responsible for planning, conducting, execution and analysis of experiments using various techniques in protein analysis. Relevant skills include HPLC/U-HPLC (HILIC, RP, SEC, CEX, AEX, affinity), capillary electrophoresis (CE), mass spec, SDS-PAGE, IEF, ELISA, qPCR. Knowledge of protein purification methods and process development/scale-up is a plus. Knowledge of Good Laboratory Practices (GLP) including analytical method qualification/validation and current Good Manufacturing Practices (cGMP) are desired. Experience in the preparation and delivery of oral and written presentations as well as participation in the preparation and submission of grants and/or manuscripts for publication are a plus. Excellent communication skills and the ability to analyze and interpret data, design appropriately controlled experiments independently, and maintain up-to-date laboratory notebooks are a must. This is an excellent opportunity to gain valuable experience with an innovative, small, young Biotech company and build a career in the biopharmaceutical industry. Candidates should feel comfortable working in a high risk/potential high reward environment and able to work overtime and weekends as project needs are determined.
Minimum Qualifications:
Benefits: BioFactura offers a competitive salary and benefit plan including health insurance (medical, dental & prescription) and a retirement plan with employer match.
Contact: Darryl Sampey, Ph.D.President and CEOBioFactura, Inc.8435 Progress Drive, Suite ZFrederick, MD 21701Cell: 240-620-3566Office: 301-315-8002www.biofactura.comdsampey@biofactura.com
What if you could really understand what someone wanted? What if by asking the right questions and listening to the words another person uses, you could better understand what they wanted – even before they did? What if you could improve all your relationships?
Improved communication and a deeper understanding of motivation is possible. By learning a repeatable framework, based on language choices that expose unconscious motivation, you can experience being ‘heard’ and better understand others. Dr. Kristin Backstrom, from the Centers for Motivation, will share insights on how language choices express what drives and motivates individuals, helping you learn how to improve teamwork, reduce conflict, and achieve goals.
Y Combinator, Silicon Valley’s best known start-up accelerator, thinks it has found a new type of biotechnology start-up.
Life-sciences companies come with a high risk of failure—often, the science behind a proposed invention isn’t entirely proven, and turns out not to work. Because of this risk, the traditional way to fund early-stage life sciences companies is for a landmark East Coast investor, such as Third Rock or Flagship, to take a huge equity stake in the business and replace the founder with a seasoned executive. In exchange, it pumps tens of millions of dollars into the company over many years. It often takes more than a decade to generate a return.
The next NIH Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Omnibus funding opportunity deadline is September 5, 2017. The National Heart, Lung, and Blood Institute (NHLBI) welcomes all investigator-initiated projects within their mission through these funding opportunities:
Along with training artists, MICA is showing more desire to educate students in creating business opportunities with their work.
That’s evident in community facing events, as the Station North arts college now runs a startup competition, and is helping students get space at OpenWorks makerspace.
Roche has bought Vienna-based diabetes management platform mySugr for an undisclosed price, the Swiss drugmaker said on Friday, joining a crowd of companies expanding app-based digital health services.
Privately held mySugr offers a logbook for mobile devices to help people track their blood sugar, medications and activity levels. It has been working with Roche since 2014 and previously got funding from Roche’s Venture Fund.
